Project Details
Description
NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Phase II Study of JNJ-42756493 (Erdatfitinib) in Patients with Tumors Harboring FGFR Alterations
| Status | Finished |
|---|---|
| Effective start/end date | 10/1/19 → 9/9/21 |
Funding
- THE CHILDREN'S HOSPITAL OF PHILADELPHIA
- LEIDOS BIOMEDICAL RESEARCH, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.